Results 121 to 130 of about 45,700 (265)

Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003–2017 [PDF]

open access: bronze, 2021
Deewa Zahir   +12 more
openalex   +1 more source

Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy

open access: yesClinical Ophthalmology, 2015
Eric K Chin, David RP Almeida, C Nathaniel Roybal, Philip I Niles, Karen M Gehrs, Elliott H Sohn, H Culver Boldt, Stephen R Russell, James C FolkDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USAPurpose: To evaluate ...
Chin EK   +8 more
doaj  

Worsening versus advanced heart failure: Management and challenges

open access: yesESC Heart Failure, EarlyView.
Clinical feature, circulating biomarkers and therapeutic management of patients with WHF versus AdvHF. Abbreviations: AdvHF, advanced heart failure; HF, heart failure; HTx, heart transplant; GDMT, guideline‐directed medical therapy; MCS, mechanical circulatory support; NYHA, New York Heart Association; WHF, worsening heart failure.
Alberto Palazzuoli   +15 more
wiley   +1 more source

Determinants of diuresis/natriuresis following ambulatory intravenous loop diuretics for worsening heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Background The use of intravenous (IV) diuretics in an outpatient setting may represent an alternative to conventional hospitalization. Our objective was to identify factors associated with diuretic response during ambulatory IV diuretic sessions in a population of advanced heart failure with no therapeutic project and a frequent flyer profile.
Michael Massin   +8 more
wiley   +1 more source

Overexpression of mineralocorticoid receptors does not affect memory and anxiety-like behavior in female mice [PDF]

open access: gold, 2015
Sofia Kanatsou   +7 more
openalex   +1 more source

Impact of early intensive GDMT on LVEF recovery and ICD decision making in de novo HFrEF

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Implantable cardioverter‐defibrillator (ICD) implantation is recommended in patients with heart failure with reduced ejection fraction (HFrEF) and left ventricular ejection fraction (LVEF) ≤ 35% after 3 months of optimized medical therapy (OMT).
Diogo Rosa Ferreira   +9 more
wiley   +1 more source

The association between polypharmacy and mortality in patients with heart failure: Results from the PULSE dataset

open access: yesESC Heart Failure, EarlyView.
A study of 660 heart failure patients (mean age 76.1) found that polypharmacy was common, with only 5% discharged without it, and 60% had died by the end of a median 2.9‐year follow‐up. In patients with heart failure with reduced ejection fraction (HFrEF), hyperpolypharmacy was associated with significantly higher mortality, while in those with ...
Janine Beezer   +4 more
wiley   +1 more source

Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats [PDF]

open access: bronze, 2015
Juan Carreno   +9 more
openalex   +1 more source

Aldosterone receptor antagonists: current perspectives and therapies

open access: yesVascular Health and Risk Management, 2013
Jason L Guichard, Donald Clark III, David A Calhoun, Mustafa I Ahmed University of Alabama at Birmingham, Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, Birmingham, AL, USA Abstract: Aldosterone is ...
Guichard JL   +3 more
doaj  

The utility of urine biomarkers in diuretic resistance prediction in heart failure hospitalization

open access: yesESC Heart Failure, EarlyView.
High urine pi‐GST concentration might be a marker for the development of loop diuretic resistance in patients with congestive heart failure hospitalization. Abstract Aims Loop diuretic resistance (LDR) in patients with heart failure hospitalization (HHF) is associated with worse clinical outcomes.
Tomasz Imiela   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy